After BioNTech SE and Pfizer, Moderna and NIH, 3rd mRNA Covid vaccine player CureVac now partners with fellow German company Bayer...

Oxford University/AstraZeneca Covid-19 vaccine, based on viral vector technology and now approved by UK authorities, will be vital for...

Infectious diseases have been largely forgotten by Pharma R&D and investors, as chronic diseases, cancer and rare diseases gave better...

Wound closure could be revolutionized with strong double-side adhesive created by MIT engineers. Contrary to existing adhesives or...